Diagnostic value of serum procalcitonin in solid organ transplant recipients: A systematic review and meta-analysis

Transplantation Proceedings

Volumn 46, Issue 1, 2014, Pages 26-32

  Yu, X Y ^a   Wang, Y ^a   Zhong, H ^a   Dou, Q L ^a   Song, Y L ^a   Wen, H ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROCALCITONIN; CALCITONIN; IMMUNOSUPPRESSIVE AGENT; PROTEIN PRECURSOR;

ARTICLE; BACTERIAL INFECTION; COCHRANE LIBRARY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMBASE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MEDLINE; META ANALYSIS; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM; SYSTEMATIC REVIEW; BLOOD; GRAFT REJECTION; PROCEDURES;

BIOLOGICAL MARKERS; CALCITONIN; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRANSPLANT RECIPIENTS;

EID: 84893525011     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.07.074     Document Type: Article

References (24)

1. J.A. Fishman Infection in solid-organ transplant recipients N Engl J Med 357 2007 2601 2614
2. A. Humar, M. Michaels, and Monitoring AIWGoID American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation Am J Transplant 6 2006 262 274
3. A.S. Chong, and M.L. Alegre The impact of infection and tissue damage in solid-organ transplantation Nat Rev Immunol 12 2012 459 471
4. D. Cooper, L. Sharples, J. Cornelissen, J. Wallwork, G. Alexander, and A. Trull Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation Transplant Proc 33 2001 1808 1810
5. J. Levitsky, A. Freifeld, and E. Lyden et al. Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors Clin Transplant 23 2009 943 950
6. V. van der Meer, A.K. Neven, P.J. van den Broek, and W.J. Assendelft Diagnostic value of C reactive protein in infections of the lower respiratory tract: Systematic review BMJ 331 2005 26
7. K.L. Becker, E.S. Nylen, J.C. White, B. Muller, and R.H. Snider Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors J Clin Endocrinol Metab 89 2004 1512 1525
8. F.M. Brunkhorst, U. Heinz, and Z.F. Forycki Kinetics of procalcitonin in iatrogenic sepsis Intensive Care Med 24 1998 888 889
9. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, and C. Bohuon High serum procalcitonin concentrations in patients with sepsis and infection Lancet 341 1993 515 518
10. P. Toikka, K. Irjala, and T. Juven et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children Pediatr Infect Dis J 19 2000 598 602
11. J. Chen, Y. Wang, Z. Shen, Z. Zhu, Y. Song, and R. Han Early diagnostic value of plasma PCT and BG assay for CRBSI after OLT Transplant Proc 43 2011 1777 1779
12. O.K. Eberhard, I. Langefeld, and E.R. Kuse et al. Procalcitonin in the early phase after renal transplantation - will it add to diagnostic accuracy? Clin Transplant 12 1998 206 211
13. E.R. Kuse, I. Langefeld, K. Jaeger, and W.R. Kulpmann Procalcitonin - a new diagnostic tool in complications following liver transplantation Intensive Care Med 26 Suppl. 2 2000 S187 S192
14. B. Prieto, E. Llorente, I. Gonzalez-Pinto, and F.V. Alvarez Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications Clin Chem Lab Med 46 2008 660 666
15. P. Whiting, A.W. Rutjes, J.B. Reitsma, P.M. Bossuyt, and J. Kleijnen The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
16. J.B. Reitsma, A.S. Glas, A.W. Rutjes, R.J. Scholten, P.M. Bossuyt, and A.H. Zwinderman Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J Clin Epidemiol 58 2005 982 990
17. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
18. R.M. Harbord, P. Whiting, and J.A. Sterne et al. An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary J Clin Epidemiol 61 2008 1095 1103
19. J.G. Lijmer, P.M. Bossuyt, and S.H. Heisterkamp Exploring sources of heterogeneity in systematic reviews of diagnostic tests Stat Med 21 2002 1525 1537
20. F. Song, K.S. Khan, J. Dinnes, and A.J. Sutton Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy Int J Epidemiol 31 2002 88 95
21. B. Suberviola, A. Castellanos-Ortega, M.A. Ballesteros, F. Zurbano, S. Naranjo, and E. Minambres Early identification of infectious complications in lung transplant recipients using procalcitonin Transpl Infect Dis 14 2012 461 467
22. T. Grammatikopoulos, A. Dhawan, and S. Bansal et al. Baseline evaluation of serum markers of inflammation and their utility in clinical practice in paediatric liver transplant recipients Clin Res Hepatol Gastroenterol 36 2012 365 370
23. A. Halkin, J. Reichman, M. Schwaber, O. Paltiel, and M. Brezis Likelihood ratios: getting diagnostic testing into perspective QJM 91 1998 247 258
24. L. Simon, F. Gauvin, D.K. Amre, P. Saint-Louis, and J. Lacroix Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis Clin Infect Dis 39 2004 206 217